Mylan offers EC concessions to get approval for $7.2 bln Meda buy
June 30, 2016 at 10:25 AM EDT
BRUSSELS, June 30 - U.S. generic drugmaker Mylan NV has offered concessions in a bid to allay concerns by EU competition regulators over its proposed $7.2-billion acquisition of Swedish rival Meda, the European Commission said on Thursday.
